Evidence map›Paper›PMID 42153487›Full record

ArticleIntegrative cancer therapies

Combination Therapy of

Dacheng Pang, Shuo Zhang, Tian Tian, Tong Wang

Abstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dacheng PangBeijing University of Chinese Medicine, P. R. China.ORCID 0009-0004-1406-1004
Shuo ZhangBeijing University of Chinese Medicine, P. R. China.
Tian TianBeijing University of Chinese Medicine, P. R. China.
Tong WangBeijing University of Chinese Medicine, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer represents a frequently seen respiratory system malignancy.

objectiveThe present work focused on investigating the inhibition of tumor cells by

methodsA549-luc2-tdT-2 cells were implanted in left lung of nude mice for establishing the orthotopic lung cancer xenograft model. After 5 days, bioluminescence imaging was conducted for model validation. Mice were later randomized as 4 groups: model,

results

conclusionThis study indicates that the combination of

Indexed as

CyclophosphamideDrugs, Chinese HerbalLung NeoplasmsA549 CellsAnimalsCell Line, TumorCell ProliferationDisease Models, AnimalExosomesHumansMiceMice, Inbred BALB CMice, NudeTumor MicroenvironmentXenograft Model Antitumor AssaysCyclophosphamideDrugs, Chinese Herbalcyclophosphamideexosomeslung cancersini decoctiontumor hypoxic microenvironment

Identifiers

PMID42153487
PMCPMC13187382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.